Search for: "Powers v. Com" Results 361 - 380 of 537
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Sep 2011, 12:07 pm by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
9 Sep 2011, 8:40 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]
2 Sep 2011, 3:45 am by Russ Bensing
That sentiment was echoed by the US First Circuit last Friday in Glik v. [read post]
29 Aug 2011, 3:37 am by Russ Bensing
  The issue in State v. [read post]
8 Aug 2011, 3:31 am by Russ Bensing
Katzenberger (2009), 178 Cal.App.4th 1260 (where attorney used power point demonstration consisting of an eight-piece jigsaw puzzle of the Statue of Liberty and argued that the jury needed only six pieces to be convinced beyond a reasonable doubt that the picture was the iconic image); United States v. [read post]
21 Jul 2011, 5:29 am by Russ Bensing
   Back in March, I told you about HB 77, which was written to overcome State v. [read post]
8 Jul 2011, 3:37 am by Andrew Frisch
Oct. 11, 2007) (citing Bazzle for the proposition that “arbitrators are well situated to answer the question whether contracts forbid[ ] class arbitration” (quotation marks omitted)); Scout. com, LLC v. [read post]
23 Jun 2011, 3:46 am by Russ Bensing
After the 8th District’s decision last week in Wallace v. [read post]
22 Jun 2011, 7:09 am by Peter Rost
"These are legitimate concerns," concedes Lewis Morris, chief counsel for the Department of Health and Human Services’ unusually powerful Inspector General’s office, which is a key player in the search for ways to combat recidivism among pharmaceutical companies. [read post]